2016. ISPOR European Congress – From Testimonials to Qualitative Research Embedded in Clinical Trials: How do HTA Bodies Consider the Voice of Rare Disease Patients When Granting Access to Orphan Drugs?

Arnould A, Upadhyaya S, Lavery C, Parker S. Issue Panel 6: From Testimonials to Qualitative Research Embedded in Clinical Trials: How do HTA Bodies Consider the Voice of Rare Disease Patients When Granting Access to Orphan Drugs? Presented at: ISPOR 19th Annual European Congress; October 31, 2016; Vienna, Austria.